EMILY GIBSON: Open Payments
NPI 1659612760 · SCOTT DEPOT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 62 payments from 12 companies in 2025. Trend: 2023 $1,100 · 2024 $1,429 · 2025 $1,085
Food & beverage: $972Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $389 |
| Janssen Biotech, Inc. | 20 | $303 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| UCB, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $33 |
| Incyte Corporation | 1 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, Bimzelx, SPEVIGO, Zoryve, TALTZ.
Industry payments across WV — which companies pay providers there.
